Skip to content
Screener

Elevance Health ELV Q3 2024 earnings

Reported October 17, 2024 · Before market open

Revenue$45.1BBeat by $1.7B
EPS$8.37Miss by $1.29
Revenue estimate$43.5B
EPS estimate$9.66

Next report

Oct 21, 2026 (In 2 weeks)
Revenue estimate$49.3B
EPS estimate$4.66

Financials

Q3 2024

Income statement

See full
Revenue$45.1B+5.3%
Gross profit$40.0B+4.7%
Net income$1.0B-21.2%
EPS (diluted)$4.36-20.0%

Balance sheet

See full
Cash & equivalents$7.9B-28.0%
Total debt$25.0B+0.5%
Total equity$43.8B+13.9%
Total assets$116.53B+5.5%

Cash flow

See full
Operating cash flow$2.7B+2.4%
CapEx$332.0M+4.1%
Free cash flow$2.3B+2.2%

Valuation & ratios

Valuation

as of 09/30/24
See full
Market cap$120.74B+17.9%
Enterprise value$137.93B+18.4%
P/E18.8×+1.7×
P/S0.7×+0.1×

Profitability

See full
Gross margin89.3%-1.1pp
Net margin3.7%+0.1pp

Returns & leverage

See full
Return on equity15.6%-0.5pp
Debt / equity0.6×-0.1×
Current ratio1.5×+0.1×

Segments

By product

See full
Service fees$2.0B-1.0%

FAQ

When did Elevance Health report Q3 2024 earnings?
Elevance Health (ELV) reported Q3 2024 earnings on October 17, 2024 before market open.
What were Elevance Health's Q3 2024 revenue and EPS?
Elevance Health reported revenue of $45.1B and eps of $8.37 for Q3 2024.
Did Elevance Health beat estimates in Q3 2024?
Revenue beat the consensus estimate of $43.5B by $1.7B. EPS missed the consensus estimate of $9.66 by $1.29.
Where can I find Elevance Health's Q3 2024 SEC filings?
You can read the 8-K earnings release (0001156039-24-000119) and the 10-Q periodic report (0001156039-24-000122) directly on SEC EDGAR. The filing index links above go to sec.gov.